Aidoc vs Viz.ai vs Qure.ai
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Aidoc
FDA-cleared AI triage for urgent CT and X-ray findings, built on its C...
Visit
|
Viz.ai
AI that flags suspected strokes on scans and pages the care team
Visit
|
|
|
|---|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 8.2 / 10 | 8.2 / 10 |
| Capability | |||
| Value for money | |||
| Ease of use | |||
| ASEAN readiness | |||
| API quality | |||
| Pricing | Enterprise | Enterprise | Enterprise |
| Free tier | — | — | No free tier; enterprise contracts only; trial demos available via sales |
| Paid from | Quoted on request per hospital or health system, no public price list | Quoted on request (demo and sales contact only, no published price) | Custom enterprise pricing; contact sales for per-scan or site-licence quotes |
| Has API | ✓ | ✓ | ✓ |
| Open source | ✗ | ✗ | ✗ |
| Free to use | ✗ | ✗ | ✗ |
| Users | nearly 2,000 hospitals worldwide; 150+ US health systems; 60M+ cases/year | Nearly 2,000 U.S. hospitals; 60,000+ providers; 230M+ lives covered | 34M+ lives impacted across 4,800+ clinical sites in 105+ countries (as of late 2025) |
| Founded | 2016 | 2016 | 2016 |
| Maker | Elad Walach (CEO), Michael Braginsky (CTO), Guy Reiner (VP R&D) | Dr. Chris Mansi (CEO, neurosurgeon) and Dr. David Golan (CTO, machine learning researcher) | Independent (Series D — Lightspeed, 360 ONE Asset, Merck GHI Fund) |
| Verdict | Aidoc is one of the most established radiology AI vendors: 35 FDA 510(k) clearances, a foundation-model triage product covering 14 abdominal CT indications, and from October 2026 a Medicare add-on payment that helps US h... |
Viz.ai pioneered AI stroke triage, and its 2018 De Novo authorisation is still the reference point for the category. Today it is a broad care-coordination platform in about 2,000 US hospitals, with 13 FDA clearances behi... |
Qure.ai is one of the most credentialled and widely deployed AI radiology platforms in the world, with a regulatory portfolio (26 FDA-cleared indications, Class IIb CE under EU MDR, CDSCO Class B in India, registrations... |
| Full review → | Full review → | Full review → |
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.